Macromolecules
Article
more hour. After the as-synthesized compound 1 (5.12 g, 15.1 mmol)
was added, the reaction temperature was increased up to 105 °C and
maintained at this temperature for 20 h. Then the solvent was
evaporated under vacuum. The obtained liquid was washed by sodium
hydroxide (4% w/w) to eliminate the residual starting materials and
dried over anhydrous magnesium sulfate. At last, the precipitate was
collected by filtration and dried in the vacuum oven to obtain the light
yellow powder (yield: 29%).
120.47 (s), 117.21 (s), 116.57 (s), 110.71 (s), 109.53 (s), 82.30 (s),
49.97 (s), 48.66 (s).
N1,N3-Bis(3-(furan-2-ylmethyl)-3,4-dihydro-2H-benzoxazine-6-
yl)isophthalamide (p-AB-fbz). p-AB-fbz was synthesized from
compound 5 (5.16 g, 14.8 mmol) following following a synthesis
procedure similar to that used for p-AF-fbz (yield: 16%).
Anal. Calcd for C34H30N4O6: C, 69.14; H, 5.12; O, 16.25; N, 9.49.
Found: C, 69.22; H, 5.14; O, 16.35; N, 9.31.
FT-IR (KBr, cm−1): 928, 1340, and 1363.
Anal. Calcd for C32H28N4O7: C, 66.20; H, 4.86; O, 19.29; N, 9.65.
Found: C, 66.19; H, 4.84; O, 19.40; N, 9.55.
1H NMR (400 MHz, CDCl3, δ, ppm): 8.34 (s, 1H), 8.15 (s, 2H),
8.00 (d, J = 7.6 Hz, 2H), 7.56 (t, J = 7.7 Hz, 1H), 7.42 (s, 4H), 7.24
(s, 2H), 6.79 (d, J = 8.7 Hz, 2H), 6.39−6.33 (m, 2H), 6.27 (d, J = 3.0
Hz, 2H), 4.87 (s, 4H), 4.00 (s, 4H), 3.91 (s, 4H).
FT-IR (KBr, cm−1): 925, 1340, and 1362.
1H NMR (400 MHz, CDCl3, δ, ppm): 8.58 (s, 2H), 8.32 (d, J = 7.5
Hz, 2H), 7.40 (t, J = 4.0 Hz, 2H), 7.31 (d, J = 5.2 Hz, 2H), 6.96 (dd, J
= 18.4, 10.5 Hz, 2H), 6.77 (d, J = 7.0 Hz, 2H), 6.32 (dt, J = 10.5, 5.3
Hz, 2H), 6.27 (t, J = 8.8 Hz, 2H), 5.01 (s, 4H), 4.03 (s, 4H), 3.92 (s,
4H).
13C NMR (400 MHz, CDCl3, δ, ppm): 165.29 (s), 151.90 (s),
151.62 (s), 143.11 (s), 135.81 (s), 131.19 (s), 130.77 (s), 129.76 (s),
125.91 (s), 121.16 (s), 120.60 (s), 117.33 (s), 110.71 (s), 109.55 (s),
82.35 (s), 50.11 (s), 48.68 (s).
13C NMR (400 MHz, CDCl3, δ, ppm): 155.23 (s), 151.29 (s),
149.03 (s), 142.85 (s), 125.70 (s), 123.06 (s), 120.88 (s), 119.41 (s),
118.78 (s), 116.60 (s), 110.30 (s), 109.23 (s), 83.03 (s), 49.11 (s),
48.53 (s).
N2,N6-bis(3-(furan-2-ylmethyl)-3,4-dihydro-2H-benzoxazine-6-
yl)pyridine-2,6-dicarboxamide (p-AP-fbz). p-AP-fbz was synthesized
from compound 6 (5.24 g, 15.0 mmol) following following a synthesis
procedure similar to that used for p-AF-fbz (yield: 17%).
Anal. Calcd for C33H29N5O6: C, 67.00; H, 4.94; O, 16.23; N, 11.84.
Found: C, 66.85; H, 5.09; O, 16.46; N, 11.73.
N1,N3-Bis(3-(furan-2-ylmethyl)-3,4-dihydro-2H-benzoxazine-8-
yl)isophthalamide (o-AB-fbz). o-AB-fbz was obtained following a
synthesis procedure similar to that used for o-AF-fbz, except for the
as-synthesized compound 2 (5.29 g, 15.2 mmol) was taken to replace
compound 1. After purified and dried in vacuum oven, a yellow
powder was obtained (yield: 32%).
FT-IR (KBr, cm−1): 928, 1340, and 1363.
1H NMR (400 MHz, CDCl3, δ, ppm): 9.45 (s, 2H), 8.44 (t, J = 9.2
Hz, 2H), 8.10 (t, J = 7.8 Hz, 1H), 7.54 (d, J = 2.3 Hz, 2H), 7.42 (d, J
= 1.1 Hz, 2H), 7.33 (dd, J = 8.7, 2.4 Hz, 2H), 6.81 (t, J = 8.5 Hz, 2H),
6.33 (dd, J = 10.3, 8.4 Hz, 2H), 6.26 (d, J = 3.0 Hz, 2H), 4.88 (s, 4H),
4.02 (s, 4H), 3.92 (s, 4H).
Anal. Calcd for C34H30N4O6: C, 69.14; H, 5.12; O, 16.25; N, 9.49.
Found: C, 69.19; H, 5.22; O, 16.21; N, 9.44.
FT-IR (KBr, cm−1): 925, 1340, and 1362.
13C NMR (400 MHz, CDCl3, δ, ppm): 161.23 (s), 151.59 (s),
151.42 (s), 149.23 (s), 142.77 (s), 139.64 (s), 130.32 (s), 125.57 (s),
120.70 (s), 120.24 (s), 117.06 (s), 110.39 (s), 109.19 (s), 82.10 (s),
49.79 (s), 48.41 (s).
1H NMR (400 MHz, CDCl3, δ, ppm): 8.51 (s, 2H), 8.45 (s, 1H),
8.38 (d, J = 8.0 Hz, 2H), 8.10 (dd, J = 7.8, 1.7 Hz, 2H), 7.65 (dd, J =
16.0, 8.2 Hz, 1H), 7.41 (t, J = 7.1 Hz, 2H), 6.96 (t, J = 7.9 Hz, 2H),
6.77 (d, J = 7.3 Hz, 2H), 6.34 (dd, J = 3.1, 1.9 Hz, 2H), 6.26 (d, J =
3.0 Hz, 2H), 5.02 (s, 4H), 4.07 (s, 4H), 3.96 (s, 4H).
13C NMR (400 MHz, CDCl3, δ, ppm): 164.35 (s), 151.30 (s),
142.79 (s), 135.86 (s), 130.24 (s), 129.35 (s), 126.33 (s), 122.66 (s),
120.68 (s), 119.22 (s), 118.42 (s), 110.26 (s), 109.12 (s), 82.88 (s),
49.00 (s), 48.38 (s).
Curing Procedure. Benzoxazine monomers were melted and
transferred to a stainless steel mold as quickly as possible. Then the
sample was cured by the programmed temperature rising method: 2 h
at 180 °C, 2 h at 200 °C, and 4 h at 220 °C. After curing reaction, the
samples were cooled down to the room temperature slowly to prevent
cracking. In this work, all of the samples including o-AF-fbz, o-AB-fbz,
o-AP-fbz, p-AF-fbz, p-AB-fbz, and p-AP-fbz were cured under the
same condition.
Measurements. NMR spectra were recorded on a 400 MHz
Bruker AVANCE III spectrometer. It was conducted at 25 °C using
DMSO-d6 or CDCl3 as the solvent. The tetramethysilane (TMS) was
used as internal standard and the times of scans was 16. For the 2D
1H−1H NOESY NMR measurement, related parameters were set as
2048 data points along the f 2 dimension, 256 free induction decays in
the f1 dimension, and relaxation delay of 2 s, and the mixing time was
700 ms.
Mass spectra were measured with a LC-Q-TOF (AB Sciex,
America) using ionization at 500 °C with an ionization voltage of
5500 V. Elementary analysis (EA) was measured by Elementar
(Elementar, Germany).
Fourier transform infrared (FT-IR) spectra were recorded in
transmission mode using a Thermo Nicolet 6700 Fourier transform
infrared spectrometer (Thermo-Fisher Scientific). Samples were
powdered and dispersed into a KBr matrix with a weight
concentration of about 1 wt %. Spectra were scanned from 400 to
4000 cm−1 with 32 scans collected for each sample. For the in situ FT-
IR measurement at various temperature (50, 100, 150, 200, and 250
°C). Cured samples were inserted into a hot cell which was adapted
to the FT-IR spectrometer, and the scan was started as soon as the hot
cell temperature reached the desired temperature.
The DSC measurement was conducted on a METTLER
TOLEDO-TGA/DSC I under a nitrogen atmosphere flow rate of
20 mL min−1. Approximately 5−10 mg of each sample was weighed
and sealed in 40 μL aluminum crucibles. The sample was heated from
50 to 300 °C at the heating rate of 10 °C min−1. In order to determine
the activation energy of polymerization, the DSC measurement was
conducted at different heating rates of 2,5, 10, and 20 °C min−1. DSC
N2,N6-Bis(3-(furan-2-ylmethyl)-3,4-dihydro-2H-benzoxazine-8-
yl)pyridine-2,6-dicarboxamide (o-AP-fbz). o-AP-fbz was obtained
following a synthesis procedure similar to that used for o-AF-fbz,
except for the as-synthesized compound 3 (5.17 g, 14.8 mmol) that
was taken to replace compound 1. After the reaction product was
purified and dried under vacuum, a yellow powder was achieved
(yield: 26%).
Anal. Calcd for C33H29N5O6: C, 67.00; H, 4.94; O, 16.23; N, 11.84.
Found: C, 66.70; H, 5.02; O, 16.41; N, 11.76.
FT-IR (KBr, cm−1): 925, 1340, and 1362.
1H NMR (400 MHz, CDCl3, δ, ppm): 9.97 (s, 2H), 8.49 (d, J = 7.8
Hz, 2H), 8.35 (t, J = 7.5 Hz, 2H), 8.17−8.10 (m, 1H), 7.36−7.30 (m,
2H), 7.02−6.96 (m, 2H), 6.79 (d, J = 7.6 Hz, 2H), 6.28−6.23 (m,
2H), 6.19 (t, J = 6.4 Hz, 2H), 4.95 (s, 4H), 4.01 (s, 4H), 3.90 (s, 4H).
13C NMR (400 MHz, CDCl3, δ, ppm): 161.49 (s), 151.27 (s),
149.63 (s), 143.82 (s), 142.76 (s), 139.48 (s), 125.90 (s), 125.59 (s),
123.22 (s), 120.81 (s), 119.53 (s), 110.35 (s), 109.23 (s), 83.08 (s),
49.21 (s), 48.44 (s).
N2,N5-Bis(3-(furan-2-ylmethyl)-3,4-dihydro-2H-benzoxazine-6-
yl)furan-2,5-dicarboxamide (p-AF-fbz). p-AF-fbz was synthesized
from compound 4 (5.02 g, 14.9 mmol) following a synthesis
procedure similar to that used for o-AF-fbz (yield: 21%).
Anal. Calcd for C32H28N4O7: C, 66.20; H, 4.86; O, 19.29; N, 9.65.
Found: C, 66.15; H, 4.91; O, 19.36; N, 9.59.
FT-IR (KBr, cm−1): 928, 1340, and 1363.
1H NMR (400 MHz, CDCl3, δ, ppm): 8.80 (s, 2H), 7.44 (s, 2H),
7.41 (d, J = 1.0 Hz, 2H), 7.23 (s, 2H), 6.75 (d, J = 8.7 Hz, 2H), 6.35−
6.32 (m, 2H), 6.25 (d, J = 3.0 Hz, 2H), 4.84 (s, 4H), 3.98 (s, 4H),
3.89 (s, 4H).
13C NMR (400 MHz, CDCl3, δ, ppm): 156.15 (s), 151.86 (s),
151.64 (s), 149.05 (s), 143.06 (s), 130.62 (s), 121.27 (s), 120.79 (s),
D
Macromolecules XXXX, XXX, XXX−XXX